Section 58-71-203 - Drug category review(1) As used in this section, "FDA" means the federal Food and Drug Administration.(2) After April 1, 2022, if the FDA adds a new drug category to the FDA's general drug category list, the division shall determine whether the drug category is consistent with the practice of naturopathic medicine.(3) To make the determination described in Subsection (2), the division shall consult with the board described in Section 58-67-201.(4) In accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, the division shall make rules to implement this section.Amended by Chapter 249, 2023 General Session ,§ 12, eff. 5/3/2023.Added by Chapter 440, 2022 General Session ,§ 2, eff. 5/4/2022.